Coultreon Biopharma Funding: $125M Raised, Series A (2026)
Coultreon Biopharma is a Biotech company based in Leuven, Belgium. It has raised $125M in total funding. Latest round: Series A.
Coultreon Biopharma funding overview
Coultreon Biopharma is a Biotech company based in Leuven, Belgium. Coultreon Biopharma has raised $125M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in April 2026. The round record for Coultreon Biopharma runs through 2026; nothing later has been disclosed. Investors on record include Novo Holdings, Regeneron's venture arm. 2 distinct backers are named across the disclosed rounds.
Coultreon Biopharma at a glance
Total raised
$125M
Latest round
Series A
Latest round date
April 2026
Industry
Biotech
Headquarters
Leuven, Belgium
Notable investors
Novo Holdings, Regeneron's venture arm
Frequently asked about Coultreon Biopharma funding
How much has Coultreon Biopharma raised?
Coultreon Biopharma has raised $125M in total disclosed funding across the rounds on record.
Who has invested in Coultreon Biopharma?
Novo Holdings, Regeneron's venture arm are named among the investors backing Coultreon Biopharma.
What was the latest Coultreon Biopharma funding round?
The most recent disclosed round is a Series A, announced in April 2026.
Where is Coultreon Biopharma based?
Coultreon Biopharma is based in Leuven, Belgium.
What sector does Coultreon Biopharma operate in?
Coultreon Biopharma is tracked under Biotech from Leuven, Belgium, with $125M in disclosed funding.
When did Coultreon Biopharma last raise?
The last disclosed Coultreon Biopharma round closed in April 2026 at Series A.
Round data for Coultreon Biopharma is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in Leuven and backer lists below.
